Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Your RPS

National Assembly for Wales calls for 'systemic changes' to antipsychotic prescribing in care homes

From left: Dr Dai Lloyd AM, Plaid Cymru, committee Chair, Sarah Rochira, Older People’s Commissioner for Wales and Lynne Neagle AM, Welsh Labour, member of the committee

Source: Iwan Hughes / Royal Pharmaceutical Society, Wales

A new report from the Welsh Assembly’s Health, Social Care and Sport Committee calls for sweeping changes to antipsychotic use in care homes. From left to right: Dai Lloyd, chair of the committee; Sarah Rochira, Older People’s Commissioner for Wales and Lynne Neagle AM, committee member, at the report’s Senedd launch on 17 May 2018 

Care home residents taking dementia medication should receive mandatory three-monthly medication reviews, the National Assembly for Wales’ Health, Social Care and Sport Committee has said. The reviews should be carried out “with a view to reducing or stopping the medication following the first review, where possible”.

The recommendation, which had been called for by the Royal Pharmaceutical Society (RPS) Wales, was made in a report published on 17 May 2018, following an inquiry into the inappropriate use of antipsychotics in care homes. Dai Lloyd, chair of the committee, said that “cultural and systemic changes are needed to ensure antipsychotic medications are prescribed appropriately, and not as a first option”.

Antipsychotics are often prescribed to help manage the psychological and behavioural symptoms of dementia, but expert bodies — including RPS Wales — had previously expressed concern about over-prescribing and inappropriate long-term use of the medicines. NICE guidelines state that patients with dementia experiencing non-cognitive symptoms, or displaying challenging behaviour, should only be given antipsychotic medicines if they are severely distressed or presenting an immediate risk of harm to themselves or others.

In the new report, the committee asks the Welsh government to ensure all health boards are fully compliant with these guidelines within 12 months. The report also said that health boards should, again within a year, collect and publish standardised data on the use of antipsychotic medication in care homes. Within six months, national dementia-care training standards for care home staff should be developed, the committee said.

Several of these interventions were also proposed by RPS Wales in its response to the committee’s inquiry. Elen Jones, interim director for RPS Wales, led the Society’s work on medicines use within care homes. Jones said she was “delighted to see that so many of our calls have been adopted by the committee, including our calls for care home residents to receive regular medication reviews, for medicines monitoring to be a key part of care home inspections and the need for all Wales training standards for care home staff”.

Jones added that she “strongly urges the Welsh government to accept these recommendations”.

Suzanne Scott-Thomas, chair of the Welsh Pharmacy Board, said it was “vital that the conditions are now created for pharmacists to work with other health professionals across the health and social care system to improve antipsychotic use”.

“I hope this report can harness pharmacist independent prescribing expertise and enable pharmacists to consult directly with residents of care homes.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20204875

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • From left: Dr Dai Lloyd AM, Plaid Cymru, committee Chair, Sarah Rochira, Older People’s Commissioner for Wales and Lynne Neagle AM, Welsh Labour, member of the committee

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.